Glucose Transporter Type 2
"Glucose Transporter Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glucose transport facilitator that is expressed primarily in PANCREATIC BETA CELLS; LIVER; and KIDNEYS. It may function as a GLUCOSE sensor to regulate INSULIN release and glucose HOMEOSTASIS.
| Descriptor ID |
D051273
|
| MeSH Number(s) |
D12.776.157.530.500.500.750 D12.776.157.530.937.563.750 D12.776.543.585.500.500.750 D12.776.543.585.937.625.750
|
| Concept/Terms |
Glucose Transporter Type 2- Glucose Transporter Type 2
- GLUT-2 Protein
- GLUT 2 Protein
- SLC2A2 Protein
- GLUT2 Protein
- Solute Carrier Family 2, Facilitated Glucose Transporter, Member 2 Protein
|
Below are MeSH descriptors whose meaning is more general than "Glucose Transporter Type 2".
Below are MeSH descriptors whose meaning is more specific than "Glucose Transporter Type 2".
This graph shows the total number of publications written about "Glucose Transporter Type 2" by people in this website by year, and whether "Glucose Transporter Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucose Transporter Type 2" by people in Profiles.
-
Intestinal stem cell-derived enteroids from morbidly obese patients preserve obesity-related phenotypes: Elevated glucose absorption and gluconeogenesis. Mol Metab. 2021 02; 44:101129.
-
Fructose metabolism and metabolic disease. J Clin Invest. 2018 02 01; 128(2):545-555.
-
A novel pancreatic ?-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice. Clin Immunol. 2014 Jul; 153(1):187-98.
-
The role of enteral fat as a modulator of body composition after small bowel resection. Surgery. 2014 Aug; 156(2):412-8.
-
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals. PLoS One. 2013; 8(1):e52062.
-
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer. Neoplasia. 2011 Feb; 13(2):180-6.
-
Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study. Cancer Epidemiol Biomarkers Prev. 2010 Feb; 19(2):558-65.
-
Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough. Ann N Y Acad Sci. 2007 Apr; 1103:19-32.
-
Glucagon-like peptide-2 protects against TPN-induced intestinal hexose malabsorption in enterally refed piglets. Am J Physiol Gastrointest Liver Physiol. 2006 Feb; 290(2):G293-300.
-
Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid. 2004 Oct; 14(10):806-12.